Racheal E Aneke, NP
Nurse Practitioner · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 2 carriers
- Offices
- 2
Offices
2 locations · Hisham Soliman MD Inc · Inland Psychiatric Medical Group Inc
Looking this up.
Plans that list them
7 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Racheal E Aneke’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$10,751
Medicare paid this office $10,751 for 40 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 28 | $4,739 | $66 |
| Short return visit (20+ min) | 15 | $2,716 | $49 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $2,379 | $44 |
| Psychiatric diagnostic evaluation with medical services | 11 | $866 | $79 |
Who their Medicare patients are
40 Original Medicare patients in 2024. Average age 59 · Under 65 53% · Women 63% · Health risk score 1.23. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 70% · High blood pressure 58%.
The office billed $35,530, Medicare allowed $15,764 and paid $10,751; for 198 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 40 | 198 | 59 | 1.23 | $35,530 | $10,751 |
| 2023 | 15 | 75 | 55 | 1.27 | $16,230 | $4,835 |
| 2022 | 20 | 96 | 68 | 1.21 | $20,880 | $5,927 |
| 2021 | 17 | 74 | 63 | 1.39 | $14,615 | $4,220 |
| 2020 | 15 | 65 | 65 | 1.34 | $14,850 | $2,799 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 11 | $1,832 | $51 |
2022: 2 services
| Return visit (30+ min) | 15 | $3,315 | $71 |
| Short return visit (20+ min) | 16 | $1,603 | $53 |
2021: 1 service
| Short return visit (20+ min) | 15 | $2,238 | $53 |
2020: 1 service
| Short return visit (20+ min) | 12 | $1,596 | $35 |
Medicaid work
$101,903 in 2024
Medicaid paid $101,903 for 1,307 billed services this clinician did in 2024, up to 65 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 495 | $48,321 |
| Short return visit (20+ min) | 461 | $29,226 |
| Psychiatric diagnostic evaluation with medical services | 237 | $17,729 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 114 | $6,627 |
| 2024 | 1,307 | 4 | 65 | $101,903 |
| 2023 | 1,858 | 5 | 82 | $139,215 |
| 2022 | 1,360 | 5 | 49 | $113,930 |
| 2021 | 1,492 | 4 | 72 | $66,618 |
| 2020 | 406 | 3 | 36 | $31,001 |
| 2019 | 59 | 2 | 20 | $5,734 |
See the largest Medicaid services in earlier years
2023
| Psychiatric diagnostic evaluation with medical services | 666 | $46,598 |
| Short return visit (20+ min) | 644 | $46,487 |
| Return visit (30+ min) | 364 | $35,724 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 150 | $7,667 |
| Psychotherapy, 45 minutes with patient | 34 | $2,740 |
2022
| Return visit (30+ min) | 450 | $45,181 |
| Psychiatric diagnostic evaluation with medical services | 411 | $41,245 |
| Short return visit (20+ min) | 365 | $26,900 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 74 | $303 |
| Screening for depression is documented as being positive and a follow-up plan is documented | 60 | $300 |
2021
| Short return visit (20+ min) | 422 | $32,454 |
| Psychiatric diagnostic evaluation with medical services | 800 | $17,716 |
| Return visit (30+ min) | 148 | $15,786 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 122 | $662 |
2020
| Short return visit (20+ min) | 274 | $16,302 |
| Psychiatric diagnostic evaluation with medical services | 83 | $10,538 |
| Return visit (30+ min) | 49 | $4,161 |
2019
| Psychiatric diagnostic evaluation with medical services | 34 | $4,274 |
| Short return visit (20+ min) | 25 | $1,460 |
Drugs they prescribed that Part D paid
$266,558
Pharmacies billed $266,558 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,170) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,075 generic and 95 brand-name prescriptions · $266,558 in drug cost · 88 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lybalvi | 18 | $40,947 | $2,275 |
| Rexulti | 27 | $39,723 | $1,471 |
| Aripiprazole | 57 | $2,310 | $41 |
| Olanzapine | 53 | $2,021 | $38 |
| Quetiapine Fumarate Er | 14 | $1,715 | $123 |
See all 32 drugs
| Lybalvi | 18 | $40,947 | $2,275 |
| Rexulti | 27 | $39,723 | $1,471 |
| Aripiprazole | 57 | $2,310 | $41 |
| Olanzapine | 53 | $2,021 | $38 |
| Quetiapine Fumarate Er | 14 | $1,715 | $123 |
| Lurasidone | 13 | $1,230 | $95 |
| Venlafaxine | 27 | $1,141 | $42 |
| Desvenlafaxine Succinate Er | 19 | $1,052 | $55 |
| Quetiapine | 89 | $936 | $11 |
| Divalproex | 38 | $887 | $23 |
| Benztropine Mesylate | 57 | $542 | $10 |
| Mirtazapine | 69 | $507 | $7 |
| Hydroxyzine Pamoate | 59 | $476 | $8 |
| Sertraline | 56 | $469 | $8 |
| Doxepin | 22 | $455 | $21 |
| Duloxetine | 45 | $449 | $10 |
| Lamotrigine | 42 | $409 | $10 |
| Gabapentin | 32 | $355 | $11 |
| Oxcarbazepine | 11 | $321 | $29 |
| Escitalopram | 57 | $318 | $6 |
| Trazodone | 43 | $230 | $5 |
| Prazosin | 26 | $191 | $7 |
| Buspirone | 28 | $190 | $7 |
| Hydroxyzine | 29 | $176 | $6 |
| Bupropion Xl | 19 | $150 | $8 |
| Venlafaxine Hcl Er | 13 | $142 | $11 |
| Paroxetine | 17 | $118 | $7 |
| Risperidone | 13 | $114 | $9 |
| Fluoxetine | 19 | $101 | $5 |
| Bupropion Hcl Sr | 20 | $86 | $4 |
| Lithium Carbonate | 13 | $81 | $6 |
| Topiramate | 11 | $67 | $6 |
Year by year
| 2024 | 1,170 | 88 | 0% (0) | 8% | $266,558 |
| 2023 | 729 | 58 | 0% (0) | 10% | $248,572 |
| 2022 | 936 | 68 | 0% (0) | 8% | $205,867 |
| 2021 | 824 | 80 | 0% (0) | 6% | $83,386 |
| 2020 | 686 | 100 | 0% (0) | 6% | $65,044 |
| 2019 | 55 | 19 | 0% (0) | None | $1,813 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Ingrezza | 14 | $101,897 | $7,278 |
| Abilify Maintena | 11 | $29,045 | $2,640 |
| Rexulti | 11 | $16,859 | $1,533 |
| Lurasidone | 13 | $11,035 | $849 |
| Aripiprazole | 18 | $3,172 | $176 |
| Quetiapine | 41 | $1,650 | $40 |
| Olanzapine | 26 | $850 | $33 |
| Venlafaxine | 17 | $806 | $47 |
| Fluoxetine | 25 | $669 | $27 |
| Mirtazapine | 47 | $595 | $13 |
| Divalproex | 34 | $587 | $17 |
| Sertraline | 32 | $570 | $18 |
| Lamotrigine | 42 | $562 | $13 |
| Duloxetine | 18 | $552 | $31 |
| Bupropion Hcl Sr | 15 | $361 | $24 |
| Gabapentin | 31 | $329 | $11 |
| Benztropine Mesylate | 34 | $323 | $9 |
| Trazodone | 40 | $300 | $8 |
| Risperidone | 18 | $236 | $13 |
| Escitalopram | 33 | $215 | $7 |
| Hydroxyzine Pamoate | 26 | $199 | $8 |
| Hydroxyzine | 26 | $165 | $6 |
| Doxepin | 14 | $163 | $12 |
| Amitriptyline | 14 | $146 | $10 |
2022: 26 drugs
| Ingrezza | 13 | $89,529 | $6,887 |
| Latuda | 24 | $50,687 | $2,112 |
| Aripiprazole | 55 | $13,284 | $242 |
| Abilify | 11 | $9,720 | $884 |
| Doxepin | 23 | $1,603 | $70 |
| Quetiapine | 60 | $1,603 | $27 |
| Sertraline | 50 | $896 | $18 |
| Fluoxetine | 41 | $732 | $18 |
| Olanzapine | 37 | $729 | $20 |
| Venlafaxine | 14 | $689 | $49 |
| Risperidone | 37 | $628 | $17 |
| Hydroxyzine | 38 | $582 | $15 |
| Mirtazapine | 56 | $576 | $10 |
| Trazodone | 46 | $550 | $12 |
| Lamotrigine | 75 | $545 | $7 |
| Benztropine Mesylate | 46 | $531 | $12 |
| Buspirone | 28 | $502 | $18 |
| Bupropion Xl | 17 | $486 | $29 |
| Divalproex | 28 | $431 | $15 |
| Gabapentin | 30 | $398 | $13 |
| Duloxetine | 16 | $388 | $24 |
| Propranolol | 12 | $272 | $23 |
| Desvenlafaxine Succinate Er | 11 | $247 | $22 |
| Hydroxyzine Pamoate | 27 | $220 | $8 |
| Escitalopram | 18 | $210 | $12 |
| Lithium Carbonate | 16 | $136 | $8 |
2021: 22 drugs
| Latuda | 22 | $32,224 | $1,465 |
| Aripiprazole | 39 | $3,319 | $85 |
| Carbamazepine Er | 11 | $2,335 | $212 |
| Quetiapine | 64 | $1,188 | $19 |
| Olanzapine | 25 | $851 | $34 |
| Mirtazapine | 64 | $786 | $12 |
| Bupropion Xl | 25 | $689 | $28 |
| Benztropine Mesylate | 49 | $652 | $13 |
| Duloxetine | 18 | $623 | $35 |
| Trazodone | 40 | $526 | $13 |
| Divalproex Sodium Er | 14 | $520 | $37 |
| Risperidone | 33 | $506 | $15 |
| Sertraline | 51 | $454 | $9 |
| Buspirone | 43 | $390 | $9 |
| Lamotrigine | 55 | $374 | $7 |
| Gabapentin | 37 | $353 | $10 |
| Hydroxyzine Pamoate | 36 | $337 | $9 |
| Fluoxetine | 27 | $270 | $10 |
| Citalopram Hbr | 16 | $234 | $15 |
| Divalproex | 16 | $209 | $13 |
| Escitalopram | 22 | $188 | $9 |
| Lithium Carbonate | 17 | $124 | $7 |
2020: 19 drugs
| Latuda | 39 | $49,218 | $1,262 |
| Aripiprazole | 27 | $1,322 | $49 |
| Quetiapine | 87 | $1,226 | $14 |
| Trazodone | 72 | $610 | $8 |
| Bupropion Xl | 19 | $457 | $24 |
| Divalproex Sodium Er | 13 | $434 | $33 |
| Hydroxyzine Pamoate | 47 | $408 | $9 |
| Buspirone | 30 | $350 | $12 |
| Escitalopram | 28 | $318 | $11 |
| Mirtazapine | 32 | $310 | $10 |
| Duloxetine | 12 | $307 | $26 |
| Sertraline | 46 | $297 | $6 |
| Gabapentin | 25 | $284 | $11 |
| Venlafaxine Hcl Er | 14 | $284 | $20 |
| Risperidone | 37 | $272 | $7 |
| Benztropine Mesylate | 15 | $197 | $13 |
| Citalopram Hbr | 15 | $169 | $11 |
| Olanzapine | 12 | $156 | $13 |
| Lamotrigine | 13 | $111 | $9 |
2019: 1 drug
| Trazodone | 11 | $115 | $10 |
Money from drug and device companies
$1,740 in 2025
| 2025 | 15 | 70 | None | $1,740 |
| 2024 | 12 | 59 | None | $1,110 |
| 2023 | 8 | 23 | None | $526 |
| 2022 | 8 | 25 | None | $621 |
| 2021 | 2 | 3 | None | $58 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $366 | 16 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $323 | 12 payments
|
| Neurocrine BioSciences | Ingrezza | $322 | 11 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $189 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $176 | 7 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $153 | 3 payments
|
See all 70 published payments
| Neurocrine BioSciences | Meals · 2025-12-01 | Ingrezza | $27 |
| Tris Pharma | Meals · 2025-11-14 | Dyanavel Xr | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-11-14 | Austedo Xr | $6 |
| Otsuka America Pharmaceutical | Meals · 2025-11-09 | Abilify Maintena | $113 |
| Teva Pharmaceuticals USA | Meals · 2025-11-04 | Uzedy | $21 |
| Teva Pharmaceuticals USA | Education · 2025-11-03 | None | $111 |
| Noven Therapeutics | Meals · 2025-10-28 | Xelstrym | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-28 | Caplyta | $18 |
| Neurocrine BioSciences | Meals · 2025-10-21 | Ingrezza | $28 |
| Supernus Pharmaceuticals | Meals · 2025-10-17 | Qelbree | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-10-10 | Abilify Asimtufii | $23 |
| Teva Pharmaceuticals USA | Meals · 2025-10-07 | Uzedy | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-09-30 | Austedo Xr | $33 |
| Neurocrine BioSciences | Meals · 2025-09-25 | Ingrezza | $28 |
| Vanda Pharmaceuticals | Meals · 2025-09-19 | Fanapt | $23 |
| Neurocrine BioSciences | Meals · 2025-09-19 | Ingrezza | $39 |
| Axsome Therapeutics | Meals · 2025-09-16 | Auvelity | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-09-16 | Uzedy | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-12 | Cobenfy | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-09-12 | Abilify Asimtufii | $18 |
| Neurocrine BioSciences | Meals · 2025-09-09 | Ingrezza | $34 |
| Otsuka America Pharmaceutical | Meals · 2025-09-05 | Abilify Asimtufii | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-26 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-26 | Caplyta | $1 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $14 |
| Otsuka America Pharmaceutical | Meals · 2025-08-12 | Rexulti | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-08-12 | Uzedy | $14 |
| Otsuka America Pharmaceutical | Meals · 2025-08-01 | Abilify Asimtufii | $10 |
| Vanda Pharmaceuticals | Meals · 2025-07-18 | Fanapt | $33 |
| Janssen Pharmaceuticals | Meals · 2025-07-13 | Invega Sustenna | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-08 | Caplyta | $27 |
| Lundbeck | Meals · 2025-07-02 | Rexulti | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-24 | Caplyta | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-17 | Cobenfy | $31 |
| Neurocrine BioSciences | Meals · 2025-06-17 | Ingrezza | $24 |
| Teva Pharmaceuticals USA | Meals · 2025-06-10 | Uzedy | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-05-27 | Uzedy | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-20 | Caplyta | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-05-13 | Abilify Asimtufii | $16 |
| Neurocrine BioSciences | Meals · 2025-04-29 | Ingrezza | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-04-25 | Rexulti | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-22 | Caplyta | $16 |
| Janssen Pharmaceuticals | Meals · 2025-04-18 | Invega Sustenna | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-04-15 | Austedo Xr | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-04-08 | Abilify Asimtufii | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-02 | Cobenfy | $30 |
| Janssen Pharmaceuticals | Meals · 2025-04-01 | Invega Sustenna | $12 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-28 | Caplyta | $20 |
| Neurocrine BioSciences | Meals · 2025-03-25 | Ingrezza | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-03-18 | Uzedy | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-12 | Cobenfy | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-11 | Cobenfy | $31 |
| Neurocrine BioSciences | Meals · 2025-03-04 | Ingrezza | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-03-04 | Uzedy | $14 |
| Neurocrine BioSciences | Meals · 2025-02-25 | Ingrezza | $34 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-19 | Cobenfy | $16 |
| Almatica Pharma | Meals · 2025-02-14 | Loreev Xr | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-11 | Caplyta | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-02-11 | Austedo Xr | $14 |
| Neurocrine BioSciences | Meals · 2025-02-04 | Ingrezza | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-01-31 | Rexulti | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-31 | Caplyta | $29 |
| Abbvie | Meals · 2025-01-24 | Vraylar | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-21 | Cobenfy | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-17 | Trintellix | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-01-17 | Austedo Xr | $7 |
| Teva Pharmaceuticals USA | Meals · 2025-01-16 | Uzedy | $16 |
| Otsuka America Pharmaceutical | Meals · 2025-01-14 | Rexulti | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-01-14 | Rexulti | $8 |
| Teva Pharmaceuticals USA | Meals · 2025-01-07 | Austedo Xr | $8 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,110
| Teva Pharmaceuticals USA | Austedo Xr | $250 | 14 payments
|
| Otsuka America Pharmaceutical | Rexulti | $245 | 15 payments
|
| Lundbeck | Rexulti | $145 | 9 payments
|
| Neurocrine Biosciences | Ingrezza | $111 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $100 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $80 | 3 payments
|
| Almatica Pharma | Loreev Xr | $56 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $37 | 2 payments
|
| Tris Pharma | Dyanavel Xr | $33 | 2 payments
|
| Noven Therapeutics | Xelstrym | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $18 | 1 payment
|
| Axsome Therapeutics | Auvelity | $15 | 1 payment
|
2023: $526
| Iti | Caplyta | $209 | 8 payments
|
| Axsome Therapeutics | Auvelity | $88 | 3 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $68 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $54 | 2 payments
|
| Lundbeck | Rexulti | $43 | 3 payments
|
| Corium | Azstarys | $35 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $15 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $13 | 1 payment
|
2022: $621
| Teva Pharmaceuticals USA | Austedo | $179 | 6 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $131 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $131 | 8 payments
|
| Iti | Caplyta | $60 | 3 payments
|
| Vanda Pharmaceuticals | Hetlioz | $51 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $29 | 1 payment
|
| Lundbeck | Rexulti | $23 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $17 | 1 payment
|
2021: $58
| Iti | Caplyta | $34 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $24 | 1 payment
|
Professional record
- NPI
- 1073071684
- Licence
- CA NP95011152
- Group
- Hisham Soliman MD Inc · Inland Psychiatric Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 3571 Mustang Dr, Ontario, CA, 91761
- NPI first listed
- 2019-03-04
- NPI last updated
- 2026-06-22
- NPI record certified
- 2026-06-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1101 Maidu Dr, Auburn, CA, 95603 · 5441 Aldrin Ct Ste A, Bakersfield, CA, 93313 · 2062 Talbert Dr Ste 100, Chico, CA, 95928 · 1245 W 6th St, Corona, CA, 92882 · 2345 Fletcher Pkwy, El Cajon, CA, 92020 · 9381 E Stockton Blvd Ste 220, Elk Grove, CA, 95624 · 15720 Ventura Blvd Ste 210, Encino, CA, 91436 · 622 Jackson St Unit 103, Fairfield, CA, 94533 · 44240 Fremont Blvd, Fremont, CA, 94538 · 4025 N Fresno St, Fresno, CA, 93726 · 2955 Main St Ste 110-K, Irvine, CA, 92614 · 509 13th St Ste 8, Modesto, CA, 95354 · 7365 Carnelian St Ste 222f, Rancho Cucamonga, CA, 91730 · 7177 Brockton Ave Ste 444a, Riverside, CA, 92506 · 9890 County Farm Rd Ste 2, Riverside, CA, 92503 · 9990 County Farm Rd, Riverside, CA, 92503 · 2440 Professional Dr, Roseville, CA, 95661 · 2386 Fair Oaks Blvd, Sacramento, CA, 95825 · 225 W Hospitality Ln # 225201p, San Bernardino, CA, 92408 · 3200 4th Ave Ste 200g, San Diego, CA, 92103 · 1254 Mission St Ste 220, San Francisco, CA, 94103 · 1040 Park Ave Ste 200-A, San Jose, CA, 95126 · 888 4th St Ste 12, San Rafael, CA, 94901 · 2222 Pacific Ave, Stockton, CA, 95204 · 1372 N Main St Ste 206-1, Walnut Creek, CA, 94596 · 1501 W Cameron Ave Ste 300-129, West Covina, CA, 91790